Featured Posts

Selasa, 29 Oktober 2013

Lowongan Kerja BUMN PT Bio Farma (Persero)

Lowongan Kerja 2013 BUMN Farmasi

PT Bio Farma (Persero) is a reputable state-owned pharmaceutical company in Indonesia with rapid business expansion, headquartered in Bandung West Java. The Company is fully owned by the Government of Indonesia. Originally registered as Parc Vaccinogene in 1890.


PT Bio Farma (Persero) was launched in 1997 to focus on human health business activity, including production of vaccine, sera, and diagnostic tools. The Company supported by 2 plants, located in Jl Pasteur Bandung for Production, R&D, Marketing and Administration and Cisarua Lembang plant for laboratory pet breeding and maintenance. Based on Bio Farma Annual Report 2011, the Company closed the business year of 2011 with a positive result marked by net sales grew by 9.79% or equivalent to Rp1.33 trillion.

PT Bio Farma (Persero) are now seeking to recruit high caliber and dynamic individuals for the following challenging positions as :

Staff SIM (Programmer)
Code : STAFF_SIM_TEL-U

Requirements

Bachelor Degree (S1) majoring in Informatics Engineering, Computer Engineering and Electro Engineering
GPA > 3.00
Single
Max age 26 years old
Experienced in develop with microsoft product (. Net), Java, C #


STAFF Bagian Infrastruktur (System Support)
Code : STAFF_INFRATRUKTUR_TEL-U

Requirements

Bachelor Degree (S1) majoring in Informatics Engineering, Computer Engineering and Electro Engineering
GPA > 3.00
Single
Max age 26 years old
Experienced in develop with microsoft product (. Net), Java, C #
Understanding of computer networks and security.


For further information, please refer official source from CDC Telkom University on following link below. Should you meet all of the requirements above, please submit your application letter, CV (better also submit your work portfolio) via email to info@infocomcareer.com cc hikmatullah@biofarma.co.id. Please write position code on your email subject. Closing date 31 October 2013.

0 komentar:

Poskan Komentar